Literatur
- 1
Wiesner B.
Epidemiologie chronisch-obstruktiver Atemwegserkrankungen.
Atemw.-Lungenkrankheiten.
1992;
18
75-78
- 2
ERS Consensus Statement .
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J.
1995;
8
1398-1420
- 3
American Thoracic Society .
Standards for the diagnosis and care of patients with chronic obstructive disease
(COPD) and asthma.
Am J Respir Crit Care Med.
1995;
152
77-120
- 4
Lange P, Parner J, Vestbo P, Schnohr P, Jensen G.
A 15-year follow-up study of ventilatory function in adults with asthma.
N Eng J Med.
1998;
339
1194-1200
- 5
Muller N L, Stapels C A, Miller R R, Abboud R T.
„Density mask”. An objective method to quantitate emphysema using computed tomography.
Chest.
1988;
94
782-787
- 6
Kohlhäufel M, Brand P, Selzer T, Scheuch G, Meyer T, Weber N, Schulz K, Häussinger K,
Heyder J.
Diagnosis of emphysema in patients with chronic bronchitis: a new approach.
Eur Respir J.
1998;
12
793-798
- 7
Magnussen H, Richter K, Taube C.
Are chronic obstructive pulmonary disease (COPD) and asthma different diseases.
Clin Exper Allergy.
1998;
28, Suppl. 5
187-194
- 8
Thurlbeck W M.
Pathology of chronic airflow obstruction.
Chest.
1990;
97
S6-S10
- 9
Leaver D G, Tattersfield A E, Pride N B.
Contributions of loss of elastic recoil and of enhanced airways collapsibility to
the airflow obstruction of chronic bronchitis and emphysema.
J Clin Invest.
1973;
52
2117-2128
- 10
Saetta M, Kim W D, Izquierdo J L, Ghezzo H, Cosio M G.
Extent of centrilobular and panacinar emphysema in smokers' lung: pathological and
mechanical implications.
Eur Respir J.
1994;
7
664-671
- 11
Brand P LP, Postma D S, Kerstjens H AM, Koeter G H. and the Dutch CNSLD Study Group
.
Relationship of airway hyperresponsiveness to respiratory symptoms and dinural peak
flow variation in patients with obstructive lung disease.
Am Rev Respir Dis.
1991;
143
916-921
- 12
British Thoracic Society .
Guidelines for the management of COPD.
Thorax.
1997;
52
S1-S28
- 13
Wettengel R, Böhning W, Cegla U, Criée C, Fichter J, Geisler L, Fabel H, Köhler D,
Konietzko N, Lindemann H, Magnussen H, Matthys H, Meister R, Morr H, Nolte D, Petro W,
Schulze-Werninghaus G, Sill V, Sybrecht G, Wiesner B, Worth H.
Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch
obstruktiver Bronchitis und Lungenemphysem.
Med Klin.
1995;
90
3-7
- 14
American Thoracic Society .
Lung function testing: Selection of reference values and interpretative strategies.
Am Rev Respir Dis.
1991;
144
1202-1228
- 15
Brand P LP, Quanjer P H, Postma D S, Kerstjens H AM, Koëter G H, Dekhuijzen P NR,
Sluiter H J. and the Dutch chronic non-specific lung disease (CNSLD) study group .
Interpretation of bronchodilator response in patients with obstructive airway disease.
Thorax.
1992;
47
429-430
- 16
Anthonisen N R, Wright E C. and the IPPB Trial Group .
Bronchodilator response in chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1986;
133
814-819
- 17
Nisar M, Harris J E, Pearson M G, Calverley P MA.
Acute bronchodilator trials in chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1992;
146
555-559
- 18
Noseda A, Schmerber J, Prigogine T, Yernault J C.
How do patients with either asthma or COPD perceive acute bronchodilatation.
Eur Respir J.
1993;
6
636-644
- 19
Gibson G J, MacNee W.
Chronic obstructive pulmonary disease: investigation and assessment of severity.
Eur Respir Mon.
1998;
7
25-40
- 20
Hay J G, Stone P, Carter J, Church S, Eyre Brook A, Pearson M G, Woodcock A A, Calvereley P MA.
Bronchodilator reversibility, exercise performance and breathlessness in stable chronic
obstructive pulmonary disease.
Eur Respir J.
1992;
5
659-664
- 21
Wegner R E, Jörres R A, Kirsten D K, Magnussen H.
Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients
with severe COPD.
Eur Respir J.
1994;
7
725-729
- 22
O'Donnell D E, Webb K A.
Exertional breathlessness in patients with chronic airflow limitation: the role of
hyperinflation.
Am Rev Respir Dis.
1993;
148
1351-1357
- 23
O'Donnell D E, Bertley J C, Chau L K, Webb K A.
Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic
mechanisms.
Am J Respir Crit Care Med.
1997;
155
109-115
- 24
O'Donnell D E, Lam M, Webb K A.
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic
obstructive pulmonary disease.
Am J Respir Crit Care Med.
1998;
158
1557-1565
- 25
Belman M J, Botnick W C, Shin J W.
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients
with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
1996;
153
967-975
- 26
O'Donnell D E, Lam M, Webb K A.
Spirometric correlates of improvement in exercise performance after anticholinergic
therapy in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
1999;
160
542-549
- 27
Koulouris N G, Valta P, Lavoie A, Corbeil C, Chasse M, Braidy M, Milic-Emili J.
A simple method to detect exspiratory flow limitation during spontaneous breathing.
Eur Respir J.
1995;
8
306-313
- 28
Valta P, Corbeil C, Lavoie A, Cammpodonico R, Koulouris N, Chasse M, Braidy J, Milic-Emili J.
Detection of expiratory flow limitation during mechanical ventilation.
Am J Respir Crit Care Med.
1994;
150
1311-1317
- 29
Tantucci C, Duguet A, Similowski T, Zelter M, Derenne J P, Milic-Emili J.
Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease
patients.
Eur Respir J.
1998;
12
799-804
- 30
Ries A L, Kaplan R M, Blumberg E.
Use of factor analysis to consolidate multiple outcome measures in chronic obstructive
pulmonary disease.
J Clin Epidemiol.
1991;
44
497-503
- 31
Mahler D A, Harver A.
A factor analysis of dyspnea ratings, respiratory muscle strength and lung function
in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1992;
145
467-470
- 32
Noseda A, Schmerber J, Prigogine T, de Maertelaer V, Yernault J C.
Perception of dyspnoea during acute changes in lung function in patients with either
asthma or COPD.
Respir Med.
1995;
89
477-485
- 33
Paré P D, Armour C, Taylor S, Mullen B, Moreno R, Hogg J C, Schellenberg R.
Airway hyperreactivity in COPD cause or effect, an in vivo in vitro comparison.
Chest.
1987;
91
S40-S44
- 34
Tiddens H AWM, Hofhuis W, Bogaard J M, Hop W CJ, de Bruin H, Willems L NA, de Jongste J C.
Compliance, hysteresis, and collapsibility of human small airways.
Am J Respir Crit Care Med.
1999;
160
1110-1118
- 35
Taube C, Lehnigk B, Paasch K, Kirsten D K, Jörres R A, Magnussen H.
Factor analysis of changes in dyspnea and lung function parameters after bronchodilation
in COPD.
Am J Respir Crit Care Med.
im Druck;
Dr. med C Taube
Pneumologisches Forschungsinstitut am Krankenhaus Großhansdorf Zentrum für Pneumologie
und Thoraxchirurgie
Wöhrendamm 80 22927 Großhansdorf
Email: E-mail: c.taube@pulmoresearch.de
